Codes for our paper "Programming Biomolecular Interactions with All-Atom Generative Model"
-
Updated
Jun 6, 2026 - Python
Codes for our paper "Programming Biomolecular Interactions with All-Atom Generative Model"
End-to-end ML pipeline for SELFIES-based molecular generation, Transformer fine-tuning, docking, and drug-likeness evaluation for HIV-1 protease inhibitors.
A bilingual work-in-progress book on AI-driven phenotypic drug discovery, from high-throughput screening and Cell Painting to machine learning and drug development.
AI-driven de novo drug discovery: LLM-in-the-loop molecular design + Vina docking + MM-GBSA + MD on EGFR T790M/L858R. Runs on a laptop, no commercial software.
Proteus: A Django-based web application for a semi-automated computational pipeline in synthetic protein design, integrating ColabFold, GROMACS, and ML ranking.
Personal academic site for Abdallah Abou Hajal - AI for drug discovery, cheminformatics, machine learning. Auto-synced from Google Scholar weekly.
Iambic Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Iambic Therapeutics is a San Diego, California AI-driven drug discovery company founded in 2019 by Thomas Miller (CEO) and Fred Manby (CTO) that designs small-molecule therapeutics for oncology and other indications.
XtalPi — independent third-party profile of a public API surface, by API Evangelist. XtalPi is an AI-and-quantum-physics drug discovery and materials research platform company with headquarters in Cambridge, Massachusetts and major operations in Beijing, Shanghai, and Shenzhen, publicly listed on the Hong Kong Stock Exchange under stock code 2228.H
To associate your repository with the ai-drug-discovery topic, visit your repo's landing page and select "manage topics."